Simplifying Global Compliance
Sun Recalls One Lot of Nimodipine on Crystallization Concerns
Washington Drug Letter
Sun Pharmaceutical is recalling one lot of its 30-mg nimodipine after a customer complaint about possible crystallization of the solution inside the capsule.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing